Home › Meningioma › New Jersey
Meningioma clinical trials in New Jersey
3 studies for Meningioma are looking for participants at sites in New Jersey.
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- Englewood Hospital and Medical Center, Englewood
- Jersey Shore Medical Center, Neptune City
- Rutgers Cancer Institute of New Jersey, New Brunswick
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT03180268Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
- Jersey Shore Medical Center, Neptune City
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT02523014Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Clinical Research dep. Davison Place. Englewood Health, Englewood
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.